Biodexa Pharmaceuticals (BDRX) Stock Chart & Stock Price History → Crypto Millionaire Says: “Buy This $11 AI Coin.” (From InvestorPlace) (Ad) Free BDRX Stock Alerts $0.96 +0.04 (+4.32%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Biodexa Pharmaceuticals Stock Price Performance5 Day Performance-3.47%1 Month Performance+5.22%3 Month Performance-43.90%6 Month Performance-63.45%Year-To-Date Performance-63.99%1 Year Performance-94.97% Receive BDRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Monetary GoldDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. BDRX Stock Chart for Tuesday, May, 14, 2024 BDRX Chart by TradingView Biodexa Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$0.92$0.97+4.34%$0.99$0.92104,944 shs$1.25 million05/10/2024$1.00$0.92-7.48%$1.00$0.92175,929 shs$1.19 million05/09/2024$1.00$1.00-0.03%$1.04$0.98113,577 shs$1.29 million05/08/2024$1.00$1.00$1.11$0.98164,599 shs$1.29 million05/07/2024$1.11$1.00-9.91%$1.09$0.99249,227 shs$1.29 million05/06/2024$1.18$1.11-5.93%$1.18$1.08308,750 shs$1.43 million Get the Latest News and Ratings for BDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$1.24$1.18-4.84%$1.28$1.17303,236 shs$1.52 million05/02/2024$1.32$1.24-6.06%$1.33$1.22319,075 shs$1.60 million05/01/2024$1.51$1.32-12.58%$1.50$1.22638,416 shs$1.70 million04/30/2024$1.31$1.51+15.27%$1.61$1.151.81 million shs$1.95 million04/29/2024$1.30$1.31+0.77%$1.33$1.083.04 million shs$1.69 million04/26/2024$0.72$1.30+80.56%$1.74$1.1470.61 million shs$1.68 million04/25/2024$0.74$0.72-2.73%$0.74$0.67138,398 shs$929,000.0004/24/2024$0.81$0.74-8.40%$0.80$0.71149,121 shs$955,000.0004/23/2024$0.77$0.81+5.63%$0.83$0.7777,430 shs$1.04 million04/22/2024$0.75$0.77+1.73%$0.79$0.75101,085 shs$985,000.0004/19/2024$0.82$0.75-8.29%$0.83$0.75150,100 shs$970,000.0004/18/2024$0.87$0.82-5.64%$0.84$0.8096,354 shs$1.06 million04/17/2024$0.86$0.87+0.99%$0.87$0.8227,587 shs$1.12 million04/16/2024$0.83$0.86+3.28%$0.87$0.81118,215 shs$1.11 million04/15/2024$0.92$0.83-9.15%$0.93$0.82129,297 shs$1.08 million04/12/2024$0.96$0.92-4.81%$0.99$0.91123,649 shs$1.18 million04/11/2024$0.98$0.96-1.86%$1.00$0.9571,425 shs$1.24 million04/10/2024$0.99$0.98-1.01%$1.00$0.95171,139 shs$1.26 million04/09/2024$1.03$0.99-3.88%$1.03$0.94113,413 shs$1.28 million04/08/2024$1.07$1.03-3.74%$1.06$1.00146,622 shs$1.33 million04/05/2024$1.16$1.07-7.76%$1.16$1.07202,289 shs$1.38 million04/04/2024$1.10$1.16+5.45%$1.20$1.11270,577 shs$1.50 million04/03/2024$1.36$1.10-19.12%$1.32$1.10785,519 shs$1.42 million04/02/2024$1.46$1.36-6.85%$1.44$1.27751,168 shs$1.75 million04/01/2024$1.62$1.46-9.88%$1.55$1.202.57 million shs$1.88 million03/29/2024$1.62$1.62$2.00$1.3587.90 million shs$2.09 million03/28/2024$0.86$1.62+88.59%$2.00$1.3588.16 million shs$2.09 million03/27/2024$0.80$0.86+7.20%$0.86$0.8084,856 shs$1.11 million03/26/2024$0.98$0.80-18.23%$0.97$0.72582,505 shs$1.03 million03/25/2024$1.05$0.98-6.67%$1.06$0.88122,562 shs$1.26 million03/22/2024$1.05$1.05$1.06$1.0449,030 shs$1.35 million03/21/2024$1.05$1.05$1.07$1.0351,312 shs$1.35 million03/20/2024$1.03$1.05+1.94%$1.05$1.0057,216 shs$1.35 million03/19/2024$1.14$1.03-9.65%$1.05$1.00243,855 shs$1.33 millionHow to Make 100X on the AI Boom (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs03/18/2024$1.17$1.14-2.56%$1.22$1.13169,264 shs$1.47 million03/15/2024$1.13$1.17+3.54%$1.19$1.1494,263 shs$1.51 million03/14/2024$1.27$1.13-11.02%$1.27$1.11229,441 shs$1.45 million03/13/2024$1.27$1.27$1.29$1.2474,567 shs$1.63 million03/12/2024$1.31$1.27-3.05%$1.30$1.2591,069 shs$1.64 million03/11/2024$1.30$1.31+0.77%$1.33$1.2770,916 shs$1.69 million03/08/2024$1.31$1.30-0.76%$1.33$1.26133,047 shs$1.68 million03/07/2024$1.29$1.31+1.55%$1.32$1.27107,300 shs$1.69 million03/06/2024$1.28$1.29+0.78%$1.34$1.25218,538 shs$1.66 million03/05/2024$1.30$1.28-1.54%$1.33$1.28133,417 shs$1.65 million03/04/2024$1.36$1.30-4.41%$1.37$1.30189,121 shs$1.67 million03/01/2024$1.27$1.36+7.09%$1.43$1.29547,856 shs$1.75 million02/29/2024$1.32$1.27-3.79%$1.35$1.26142,334 shs$1.64 million02/28/2024$1.38$1.32-4.35%$1.35$1.24286,380 shs$1.70 million02/27/2024$1.39$1.38-0.72%$1.39$1.33121,665 shs$1.78 million02/26/2024$1.49$1.39-6.71%$1.45$1.31317,409 shs$1.79 million02/23/2024$1.54$1.49-3.25%$1.73$1.314.11 million shs$1.92 million02/22/2024$1.53$1.54+0.65%$1.57$1.51149,147 shs$1.99 million02/21/2024$1.62$1.53-5.56%$1.62$1.53222,641 shs$1.97 million02/20/2024$1.55$1.62+4.52%$1.64$1.50268,687 shs$2.09 million02/19/2024$1.55$1.55$1.60$1.51278,800 shs$2 million02/16/2024$1.59$1.55-2.52%$1.60$1.51257,583 shs$2 million02/15/2024$1.72$1.59-7.56%$1.67$1.55441,010 shs$2.05 million02/14/2024$1.80$1.72-4.44%$1.82$1.62959,183 shs$2.21 million02/13/2024$1.45$1.80+24.14%$2.11$1.5811.86 million shs$2.32 million Related Companies: GRI Bio Stock Chart Panbela Therapeutics Stock Chart Lucy Scientific Discovery Stock Chart NeuBase Therapeutics Stock Chart Sunshine Biopharma Stock Chart InMed Pharmaceuticals Stock Chart Evelo Biosciences Stock Chart 180 Life Sciences Stock Chart SciSparc Stock Chart PainReform Stock Chart Receive BDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BDRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportGuard Against the Coming Financial UpheavalPorter & CompanyDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThis 1 Biotech Stock has been shocking the marketsHuge AlertsElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.